STOCK TITAN

John C. Jacobs, President and CEO of Harmony Biosciences, Joins Life Sciences Pennsylvania Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Harmony Biosciences announced the appointment of John C. Jacobs as a member of the Life Sciences Pennsylvania's Board of Directors, effective May 6, 2021. Under his leadership, Harmony has focused on innovative therapies for rare neurological disorders. Jacobs brings almost three decades of experience in the pharmaceutical sector, enhancing his ability to support local patient communities and advance the life sciences industry in Pennsylvania. His appointment underscores Harmony’s commitment to leadership within the sector and aims to bolster the company’s influence and initiatives in the region.

Positive
  • John C. Jacobs' appointment to the LSPA Board can enhance networking opportunities for Harmony.
  • Jacobs' extensive expertise in pharmaceutical and life sciences will provide strategic insights for Harmony.
Negative
  • None.

PLYMOUTH MEETING, Pa., May 18, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today announced the appointment of John C. Jacobs, President and CEO of Harmony, to the Life Sciences Pennsylvania's (LSPA) Board of Directors, effective May 6, 2021.

John Jacobs' election to the board is accompanied by other leaders representing the breadth, diversity and geographic reach of LSPA across the medical device, diagnostic, biopharmaceutical, and research communities, bringing important expertise, insights, and partnerships that will help enhance the association's effectiveness. He will provide insight and guidance to the association given his deep experience of almost three decades in the pharmaceutical and life sciences industry.

"The appointment of John to the Board of Directors is a testament to the work done by Harmony under his leadership to help the local patient community and raise the profile of life science companies in the region. We are grateful that John has agreed to serve on LSPA's Board of Directors and we look forward to working with him to advance the Association's initiatives," said Christopher P. Molineaux, President and CEO of Life Sciences Pennsylvania. 

"Life Sciences Pennsylvania plays a critical and inspiring role in supporting and elevating the life sciences industry in Pennsylvania," Jacobs said. "I am honored to be joining the Board and helping to continue to make Pennsylvania a global life sciences leader."

About Harmony Biosciences 
Harmony Biosciences is a pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, with a vision to provide novel treatment options for people living with rare neurological disorders who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

About Life Sciences Pennsylvania
Life Sciences Pennsylvania (LSPA) is the trade association for the Commonwealth's life sciences community. Founded in 1989, LSPA works to ensure Pennsylvania has a business and public policy climate that unites and incentivizes all facets of the state's diverse life sciences economy.

LSPA represents biotechnology, medical device, diagnostic, pharmaceutical, research, and investment entities, along with myriad service providers who support the industry. Together, we unify Pennsylvania's innovators to make the Commonwealth a global life sciences leader.

Harmony Biosciences Media Contact: 

Nancy Leone 
215-891-6046 
nleone@harmonybiosciences.com 

Harmony Biosciences Investor Contact: 

Lisa Caperelli 
484-539-9736 
lcaperelli@harmonybiosciences.com 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/john-c-jacobs-president-and-ceo-of-harmony-biosciences-joins-life-sciences-pennsylvania-board-of-directors-301293009.html

SOURCE Harmony Biosciences

FAQ

Who is John C. Jacobs and what role does he serve at Harmony Biosciences?

John C. Jacobs is the President and CEO of Harmony Biosciences, focused on developing treatments for rare neurological disorders.

When did John C. Jacobs join the Life Sciences Pennsylvania's Board of Directors?

John C. Jacobs joined the Life Sciences Pennsylvania's Board of Directors effective May 6, 2021.

What impact might John C. Jacobs' appointment have on Harmony Biosciences?

Jacobs' appointment may expand Harmony's influence and provide valuable insights, enhancing its initiatives in the life sciences sector.

Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

HRMY Rankings

HRMY Latest News

HRMY Stock Data

1.94B
38.55M
11.62%
93.1%
10.17%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PLYMOUTH MEETING